The 61st International Conference on Medicinal Chemistry (RICT 2027) explores cutting-edge chemical strategies for drug discovery, focusing on the development of novel molecular agents for neurodegenerative diseases, anti-infectives, and immunological therapies.
Key Topics
- Neurodegenerative diseases
- Next Generation of Anti-infective Agents
- New Avenues in Drug Discovery Chemistry
- Small Molecules for Immunooncology or Autoimmunity
- Case studies in Selected Therapeutic Areas
- New Molecular Landscapes in Drug Discovery
- Late-Breaking Topics: First Disclosures of Clinical Candidates
